We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Biodegradable Nanoscaffolds Improve Chances for Stem Cell Therapies

By LabMedica International staff writers
Posted on 15 Nov 2018
The therapeutic potential of biodegradable nanoscaffolds made from manganese dioxide (MnO2) for advanced stem cell transplantation and neural tissue engineering was discussed favorably in a recent paper.

Stem cell transplantation, as a promising treatment for central nervous system diseases, has been hampered by crucial issues such as a low cell survival rate, incomplete differentiation, and limited neurite outgrowth in vivo. More...
Inorganic and carbon-based nanoscaffolds designed to support and improve stem cell growth have been handicapped by their non-biodegradability and restricted biocompatibility, thereby delaying their wide clinical applications. On the contrary, MnO2 nanomaterials have proven to be biodegradable in other bio-applications such as cancer therapies, with MRI active Mn2+ ions as a degradation product.

Investigators at Rutgers University (New Brunswick, NJ, USA) designed nanoscaffolds that mimicked the natural tissue microenvironment to deliver physical and soluble cues. They took advantage of the biodegradability of MnO2 to incorporate its unique physiochemical properties into nano-sized structures for stem cell-based tissue engineering. The result, as described in the August 8, 2018, online edition of the journal Nature Communications was MnO2 nanomaterials-based three-dimensional hybrid nanoscaffolds that better regulated stem cell adhesion, differentiation into neurons, and neurite outgrowth in vitro and enabled enhanced stem cell transplantation benefits in vivo.

These biodegradable MnO2 nanoscaffolds could potentially serve as powerful tools for improving stem cell transplantation and advancing stem cell therapy.

"It has been a major challenge to develop a reliable therapeutic method for treating central nervous system diseases and injuries," said senior author Dr. KiBum Lee, professor of chemistry and chemical biology at Rutgers University. "Our enhanced stem cell transplantation approach is an innovative potential solution."

Related Links:
Rutgers University


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
DNA/RNA Extraction/Purification Kit
Nucleic Acid Extraction or Purification Kit
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.